Is Universe Pharmaceuticals Stock a Good Investment?
Universe Pharmaceuticals Investment Advice | UPC |
- Examine Universe Pharmaceuticals' financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Universe Pharmaceuticals' leadership team and their track record. Good management can help Universe Pharmaceuticals navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Biotechnology space and any emerging trends that could impact Universe Pharmaceuticals' business and its evolving consumer preferences.
- Compare Universe Pharmaceuticals' performance and market position to its competitors. Analyze how Universe Pharmaceuticals is positioned in terms of product offerings, innovation, and market share.
- Check if Universe Pharmaceuticals pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Universe Pharmaceuticals' stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Universe Pharmaceuticals stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Universe Pharmaceuticals is a good investment.
Sell | Buy |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Abnormally volatile | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Above Average | Details | |
Economic Sensitivity | Very regressive towards the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Not Available | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unavailable | Details |
Examine Universe Pharmaceuticals Stock
Researching Universe Pharmaceuticals' stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). The company has Price to Book (P/B) ratio of 0.11. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. Universe Pharmaceuticals recorded a loss per share of 76.35. The entity had not issued any dividends in recent years. The firm had 1:15 split on the 18th of November 2024.
To determine if Universe Pharmaceuticals is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Universe Pharmaceuticals' research are outlined below:
| Universe Pharmaceuticals generated a negative expected return over the last 90 days | |
| Universe Pharmaceuticals has high historical volatility and very poor performance | |
| Universe Pharmaceuticals may become a speculative penny stock | |
| Universe Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the last year's revenue of 32.31 M. Reported Net Loss for the year was (6.16 M) with profit before taxes, overhead, and interest of 21.89 M. | |
| Latest headline from news.google.com: Universe Pharmaceuticals stock hits 52-week low at 1.78 By Investing.com - Investing.com Australia |
Universe Pharmaceuticals Quarterly Cash And Short Term Investments |
|
Universe Pharmaceuticals uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Universe Pharmaceuticals. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Universe Pharmaceuticals' previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 9th of February 2024 Upcoming Quarterly Report | View | |
| 30th of September 2023 Next Fiscal Quarter End | View |
Know Universe Pharmaceuticals' Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Universe Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Universe Pharmaceuticals backward and forwards among themselves. Universe Pharmaceuticals' institutional investor refers to the entity that pools money to purchase Universe Pharmaceuticals' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Renaissance Technologies Corp | 2024-09-30 | 39.3 K | Ubs Group Ag | 2024-06-30 | 5.2 K |
Universe Pharmaceuticals' market capitalization trends
The company currently falls under 'Nano-Cap' category with a total capitalization of 2.82 M.Market Cap |
|
Universe Pharmaceuticals' profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.12) | (0.13) | |
| Return On Capital Employed | (0.10) | (0.10) | |
| Return On Assets | (0.12) | (0.13) | |
| Return On Equity | (0.18) | (0.17) |
Determining Universe Pharmaceuticals' profitability involves analyzing its financial statements and using various financial metrics to determine if Universe Pharmaceuticals is a good buy. For example, gross profit margin measures Universe Pharmaceuticals' profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Universe Pharmaceuticals' profitability and make more informed investment decisions.
Please note, the presentation of Universe Pharmaceuticals' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Universe Pharmaceuticals' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Universe Pharmaceuticals' management manipulating its earnings.
Evaluate Universe Pharmaceuticals' management efficiency
Universe Pharmaceuticals has Return on Asset of (0.0565) % which means that on every $100 spent on assets, it lost $0.0565. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.5022) %, meaning that it generated no profit with money invested by stockholders. Universe Pharmaceuticals' management efficiency ratios could be used to measure how well Universe Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. As of November 22, 2024, Return On Tangible Assets is expected to decline to -0.13. The current year's Return On Capital Employed is expected to grow to -0.1. At present, Universe Pharmaceuticals' Intangible Assets are projected to decrease significantly based on the last few years of reporting. The current year's Intangibles To Total Assets is expected to grow to 0.01, whereas Total Assets are forecasted to decline to about 47.2 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 9.82 | 6.59 | |
| Tangible Book Value Per Share | 9.78 | 6.56 | |
| Enterprise Value Over EBITDA | (18.55) | (17.62) | |
| Price Book Value Ratio | 1.50 | 1.43 | |
| Enterprise Value Multiple | (18.55) | (17.62) | |
| Price Fair Value | 1.50 | 1.43 |
Effective leadership at Universe Pharmaceuticals drives its competitive edge in the market. Our analysis focuses on how this translates to financial performance and stock value.
Beta 1.544 |
Basic technical analysis of Universe Stock
As of the 22nd of November, Universe Pharmaceuticals has the Variance of 161.14, coefficient of variation of (342.82), and Risk Adjusted Performance of (0.21). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Universe Pharmaceuticals, as well as the relationship between them.Universe Pharmaceuticals' insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Universe Pharmaceuticals insiders, such as employees or executives, is commonly permitted as long as it does not rely on Universe Pharmaceuticals' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Universe Pharmaceuticals insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
White John V over three months ago Acquisition by White John V of 10050 shares of Universe Pharmaceuticals at 19.1667 subject to Rule 16b-3 | ||
Trippeer Richard A Jr over six months ago Acquisition by Trippeer Richard A Jr of 6200 shares of Universe Pharmaceuticals at 33.48 subject to Rule 16b-3 | ||
Moore Jackson W over six months ago Acquisition by Moore Jackson W of 308212 shares of Universe Pharmaceuticals at 29.22 subject to Rule 16b-3 | ||
Moore Jackson W over six months ago Acquisition by Moore Jackson W of 13100 shares of Universe Pharmaceuticals subject to Rule 16b-3 |
Universe Pharmaceuticals' Outstanding Corporate Bonds
Universe Pharmaceuticals issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Universe Pharmaceuticals uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Universe bonds can be classified according to their maturity, which is the date when Universe Pharmaceuticals has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
Understand Universe Pharmaceuticals' technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Universe Pharmaceuticals' various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | (0.21) | |||
| Market Risk Adjusted Performance | 9.45 | |||
| Mean Deviation | 7.66 | |||
| Coefficient Of Variation | (342.82) | |||
| Standard Deviation | 12.69 | |||
| Variance | 161.14 | |||
| Information Ratio | (0.30) | |||
| Jensen Alpha | (3.67) | |||
| Total Risk Alpha | (5.37) | |||
| Treynor Ratio | 9.44 | |||
| Maximum Drawdown | 74.66 | |||
| Value At Risk | (16.26) | |||
| Potential Upside | 12.27 | |||
| Skewness | (2.15) | |||
| Kurtosis | 10.6 |
| Risk Adjusted Performance | (0.21) | |||
| Market Risk Adjusted Performance | 9.45 | |||
| Mean Deviation | 7.66 | |||
| Coefficient Of Variation | (342.82) | |||
| Standard Deviation | 12.69 | |||
| Variance | 161.14 | |||
| Information Ratio | (0.30) | |||
| Jensen Alpha | (3.67) | |||
| Total Risk Alpha | (5.37) | |||
| Treynor Ratio | 9.44 | |||
| Maximum Drawdown | 74.66 | |||
| Value At Risk | (16.26) | |||
| Potential Upside | 12.27 | |||
| Skewness | (2.15) | |||
| Kurtosis | 10.6 |
Consider Universe Pharmaceuticals' intraday indicators
Universe Pharmaceuticals intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Universe Pharmaceuticals stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Universe Pharmaceuticals time-series forecasting models is one of many Universe Pharmaceuticals' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Universe Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
Universe Stock media impact
Far too much social signal, news, headlines, and media speculation about Universe Pharmaceuticals that are available to investors today. That information is available publicly through Universe media outlets and privately through word of mouth or via Universe internal channels. However, regardless of the origin, that massive amount of Universe data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Universe Pharmaceuticals news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Universe Pharmaceuticals relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Universe Pharmaceuticals' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Universe Pharmaceuticals alpha.
Universe Pharmaceuticals Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Universe Pharmaceuticals can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
When determining whether Universe Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Universe Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Universe Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Universe Pharmaceuticals Stock: Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Universe Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. For information on how to trade Universe Stock refer to our How to Trade Universe Stock guide.You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Universe Pharmaceuticals. If investors know Universe will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Universe Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.82) | Earnings Share (76.35) | Revenue Per Share 7.351 | Quarterly Revenue Growth (0.30) | Return On Assets (0.06) |
The market value of Universe Pharmaceuticals is measured differently than its book value, which is the value of Universe that is recorded on the company's balance sheet. Investors also form their own opinion of Universe Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Universe Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Universe Pharmaceuticals' market value can be influenced by many factors that don't directly affect Universe Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Universe Pharmaceuticals' value and its price, as these two are different measures arrived at by various means. Investors typically determine if Universe Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Universe Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.